SLC47A1 and gastric cancer: These findings suggest a potential mechanism in which ALDH3A2 downregulates SLC47A1, thereby restricting NRF2 nuclear translocation, impairing UPRmt function, and promoting ferroptosis, which may ultimately contribute to the malignant progression of GC.